Search results
Results from the WOW.Com Content Network
Insulin lispro hexamer. Insulin lispro, marketed under the brand name Humalog among others, is a modified form of medical insulin used to treat both type 1 and type 2 diabetes. [21] It is administered subcutaneously through injection or an insulin pump. [21] [22] The effects typically begin within 30 minutes and last for about 5 hours. [21]
Insulin lispro, sold under the brand name Humalog among others, is a modified type of medical insulin used to treat type 1 and type 2 diabetes. [5] It is delivered subcutaneously either by injection or from an insulin pump .
This is an ultralong-acting insulin analogue developed by Novo Nordisk, which markets it under the brand name Tresiba. It is administered once daily and has a duration of action that lasts up to 40 hours (compared to 18 to 26 hours provided by other marketed long-acting insulins such as insulin glargine and insulin detemir).
Brand Name(s) Generic Name Sales Q1 2014 Sales ($000) Change from Q4 2013 ... Insulin lispro: 304,866: 6.15%: Eli Lilly and Company: Diabetes mellitus type 1 and 2 ...
Walmart said the vials would retail for $72.88 and the FlexPens for $85.88, saving consumers between 58% and 75% off the cash price for other insulin products, equating savings of up to $101 per ...
The annual cost of insulin for people with type 1 diabetes in the US almost doubled from $2,900 to $5,700 over the period from 2012 to 2016. [97] In 2019, it was estimated that people in the US pay two to six times more than the rest of the world for brand name prescription medicine, according to the International Federation of Health Plans. [98]
Lixisenatide is used as adjunct to diet and exercise to treat type 2 diabetes. [3] In the European Union, its use is limited to complementing insulin therapy. [2] [4] As of 2017 it is unclear if they affect a person's risk of death. [5] It is provided in an autoinjector containing fourteen doses and is injected subcutaneously. [3]
ATC code A10 Drugs used in diabetes is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.